Dr. Sulaiman Al Habib Medical S vs Dallah Healthcare Co.
A head-to-head of Dr. Sulaiman Al Habib Medical S (4013) and Dallah Healthcare Co. (4004) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4013 | 4004 |
|---|---|---|
| Market Cap | 75.29B SAR | 10.78B SAR |
| P/E (TTM) | 31.36 | 20.02 |
| Forward P/E | 28.64 | 20.80 |
| P/S | 5.45 | 2.67 |
| P/B | 9.47 | 2.64 |
| EV/EBITDA | 26.07 | 20.79 |
| Dividend Yield | 1.85% | 1.79% |
| Profit Margin | 16.79% | 11.15% |
| Gross Margin | 30.69% | 35.71% |
| Operating Margin | 19.26% | 15.40% |
| Revenue Growth (YoY) | +8.80% | +21.68% |
| FCF Yield | 0.81% | -0.21% |
| Debt / Equity | 113.79 | 94.09 |
| Current Ratio | 1.14 | 1.20 |
Which is better: Dr. Sulaiman Al Habib Medical S or Dallah Healthcare Co.?
- ✓Larger by market cap: Dr. Sulaiman Al Habib Medical S
- ✓Cheaper valuation (lower P/E): Dallah Healthcare Co.
- ✓Higher dividend yield: Dr. Sulaiman Al Habib Medical S
- ✓More profitable (net margin): Dr. Sulaiman Al Habib Medical S
- ✓Faster revenue growth: Dallah Healthcare Co.
- ✓Higher free-cash-flow yield: Dr. Sulaiman Al Habib Medical S
Across 13 available metrics, Dallah Healthcare Co. leads 9–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Dr. Sulaiman Al Habib Medical S with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.